Unknown

Dataset Information

0

Analysis of the molecular mechanism of Pudilan (PDL) treatment for COVID-19 by network pharmacology tools.


ABSTRACT: BACKGROUND:Pudilan (PDL), a four-herb prescription with the traditional function of heat-clearing and detoxifying, has been clinically used as an anti-SARS-CoV-2 infectory agent in China. PDL might also have therapeutic potentials for COVID-19 while the underlying mechanisms remain to be clarified. METHODS:We used network pharmacology analysis and selected 68 co-targeted genes/proteins as targets of both PDL and COVID-19. These co-targeted genes/proteins were predicted by SwissDock Server for their high-precision docking simulation, and analyzed by STRING for proteins to protein interaction (PPI), pathway and GO (gene ontology) enrichment. The therapeutic effect for PDL treatment on COVID-19 was validated by the TCMATCOV (TCM Anti COVID-19) platform. RESULTS:PDL might prevent the entrance of SARS-CoV-2 entry into cells by blocking the angiotensin-converting enzyme 2 (ACE2). It might inhibit the cytokine storm by affecting C-reactive protein (CRP), interferon-? (IFN-?), interleukin- 6 (IL-6), interleukin- 10 (IL-10), tumor necrosis factor (TNF), epidermal growth factor receptor (EGFR), C-C motif chemokine ligand 5 (CCL5), transforming growth factor-?1 (TGF?1), and other proteins. PDL might moderate the immune system to shorten the course of the disease, delay disease progression, and reduce the mortality rate. CONCLUSION:PDL might have a therapeutic effect on COVID-19 through three aspects, including the moderate immune system, anti-inflammation, and anti-virus entry into cells.

SUBMITTER: Kong Q 

PROVIDER: S-EPMC7260557 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Analysis of the molecular mechanism of Pudilan (PDL) treatment for COVID-19 by network pharmacology tools.

Kong Qi Q   Wu Yue Y   Gu Yu Y   Lv Qi Q   Qi Feifei F   Gong Shuran S   Chen Xiuping X  

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20200530


<h4>Background</h4>Pudilan (PDL), a four-herb prescription with the traditional function of heat-clearing and detoxifying, has been clinically used as an anti-SARS-CoV-2 infectory agent in China. PDL might also have therapeutic potentials for COVID-19 while the underlying mechanisms remain to be clarified.<h4>Methods</h4>We used network pharmacology analysis and selected 68 co-targeted genes/proteins as targets of both PDL and COVID-19. These co-targeted genes/proteins were predicted by SwissDoc  ...[more]

Similar Datasets

| S-EPMC7836709 | biostudies-literature
| S-EPMC8902854 | biostudies-literature
| S-EPMC7391051 | biostudies-literature
| S-EPMC7277311 | biostudies-literature
| S-EPMC7829483 | biostudies-literature
| S-EPMC9035664 | biostudies-literature
| S-EPMC8895682 | biostudies-literature
| S-EPMC8187140 | biostudies-literature
| S-EPMC7441778 | biostudies-literature
| S-EPMC8735807 | biostudies-literature